Master BillingRevenue Specialists
Expert analysis on coding updates, denial strategies, payer trends, and revenue optimization — written exclusively for dermatology practices.
CPT 17311–17315, modifier usage, and the documentation gaps that drive denials. Stage-by-stage guidance for capturing every billable unit on multi-stage cases.
PA volume is climbing for biologics and specialty treatments. The workflow design, payer-specific tactics, and documentation patterns that move approvals faster.
53 million prior auth determinations. 4.1 million denials. An 80.7% overturn rate on appeal. CMS's new interoperability rule rewrites the rules — if your practice is ready.
Practices lose up to 23% of revenue to incomplete charge capture. The documentation gaps, missed procedures, and workflow fixes to recover ~$47K per provider annually.
Self-pay recovery strategies, payment plan workflows, and proven tactics to reduce 90+ day AR.
What your clinical notes must include to defeat machine-driven denials on biologic prior auths.
How automated payer review systems target modifier 25, and how to fight back successfully.
Fee schedule benchmarking, leverage points, and tactics to win better rates from commercial payers.
The complete enrollment workflow: CAQH, payer submission, follow-up, and effective date tracking.
MD fined Cigna $80K. 5-step playbook to protect your E/M revenue.
Electronic claims attachments required. 24-month compliance window.
Home visits, audio-only continue. But it's not permanent yet.
Triple the addressable market. Reimbursement may increase to $230.
Voice AI cuts calls 40%. ChatGPT interprets patient records. What to adopt.
Oral psoriasis biologic. Pharmacy benefit billing. PA implications.
Lawmakers push to halt WISER. BCBS reforms PA. California waives PAs approved 90%+ of the time.
New lipodystrophy, ulcer, abscess codes + xylazine wound category.
Four new CPT codes replace 77401, 0394T, G6001. Reimbursement may increase.
MAC processing errors causing telehealth denials. How to resubmit.
Fourth extension of controlled substance prescribing via telehealth.
Net ~0.8% increase. Skin substitutes reclassified. What it means for derm.
UHC cuts MA plans. ACA rates +25%. Cigna rebate-free PBM. AI claims review.
Complete checklist: ICD-10, CPT, SRT, skin substitutes, fee schedule.
When to use each modifier, documentation requirements, 2026 audit triggers, and the XS/XE alternatives.
The 90-day playbook: analyze, prevent, optimize. Cut your 14% denial rate in half.
CMS reclassified CTPs to incident-to supplies at $127/sq cm. 158 products delisted. Prior auth in 6 states.
POS 02 vs POS 10 vs POS 11 — stop the #1 cause of telehealth claim rejections with payer-specific workflows.
A comprehensive breakdown of the key CPT code revisions affecting dermatology — including updated destruction, biopsy, and Mohs codes.
Systematic appeal strategies that recover 89% of initially denied dermatology claims.
Stage-by-stage guidance on properly documenting and coding Mohs micrographic surgery.
A state-by-state breakdown of new prior authorization reform legislation for dermatology practices.
Analysis of shifting reimbursement rates across major commercial payers with contract negotiation strategies.
How PE-backed dermatology platforms can maintain billing performance during rapid growth and M&A integration.
Discover how much revenue your dermatology practice is leaving on the table. Our complimentary assessment identifies coding gaps, denial patterns, and collection opportunities.